One of the most exciting and lucrative avenues of stock investing is in the biotech arena. It can also be one of the most dangerous.#-ad_banner-# The sector focuses on developing and marketing lifesaving drugs and other medical breakthroughs. These products can have profound constructive effects on the world. Not only have many investors built fortunes by investing in biotech, but it feels good to know you’re helping to fund such positive research and development. Tiny biotech companies can make their investors a fortune when they’re acquired by their larger brethren or bring a revolutionary product to market. Short-term… Read More
One of the most exciting and lucrative avenues of stock investing is in the biotech arena. It can also be one of the most dangerous.#-ad_banner-# The sector focuses on developing and marketing lifesaving drugs and other medical breakthroughs. These products can have profound constructive effects on the world. Not only have many investors built fortunes by investing in biotech, but it feels good to know you’re helping to fund such positive research and development. Tiny biotech companies can make their investors a fortune when they’re acquired by their larger brethren or bring a revolutionary product to market. Short-term profits can abound when these companies make bullish product announcements or pass Food and Drug Administration (FDA) requirements, as well as for a host of other reasons. The Dangerous Side However, biotech companies are among the market’s most inherently volatile stocks. Many of these companies don’t generate revenue and are burning cash like crazy on research and development. It’s a race between this burn rate and the company’s ability to get its products to market (or raise more cash to continue operations). In other words, early stage biotechs are highly speculative. As products are brought to market, the company… Read More